BIOATLA, INC. Increase Decrease In Operating Lease Liability
BIOATLA, INC. (BCAB) reported Increase Decrease In Operating Lease Liability of $110.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- BIOATLA, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$6.00K.
- BIOATLA, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $116.00K.
- BIOATLA, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $238.00K.
- BIOATLA, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $358.00K.
- BIOATLA, INC. increase decrease in operating lease liability for fiscal 2025 was $344.00K.
- BIOATLA, INC. increase decrease in operating lease liability for fiscal 2024 was -$641.00K.
- BIOATLA, INC. increase decrease in operating lease liability for fiscal 2023 was -$593.00K.
- BIOATLA, INC. increase decrease in operating lease liability for fiscal 2022 was -$513.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $110.00K 10-Q · filed 2026-08-13 | $348.00K derived: sum of 3 quarters · filed 2026-08-13 | $706.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $116.00K 10-Q · filed 2026-05-15 | $354.00K derived: sum of 2 quarters · filed 2026-05-15 | $712.00K derived: sum of 3 quarters · filed 2026-05-15 | $488.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $596.00K derived: sum of 2 quarters · filed 2026-03-31 | $372.00K derived: sum of 3 quarters · filed 2026-08-13 | $344.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $134.00K derived: sum of 2 quarters · filed 2026-08-13 | $106.00K 10-Q · filed 2025-11-13 | -$58.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$252.00K 10-Q · filed 2026-08-13 | -$416.00K derived: sum of 3 quarters · filed 2026-08-13 | -$579.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$28.00K 10-Q · filed 2026-05-15 | -$192.00K derived: sum of 2 quarters · filed 2026-05-15 | -$355.00K derived: sum of 3 quarters · filed 2026-05-15 | -$373.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$327.00K derived: sum of 2 quarters · filed 2026-03-31 | -$345.00K derived: sum of 3 quarters · filed 2026-03-31 | -$641.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$181.00K derived: sum of 2 quarters · filed 2025-11-13 | -$477.00K 10-Q · filed 2025-11-13 | -$627.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$314.00K 10-Q · filed 2025-08-07 | -$464.00K derived: sum of 3 quarters · filed 2025-08-07 | -$614.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$296.00K 10-Q · filed 2025-05-06 | -$446.00K derived: sum of 2 quarters · filed 2025-05-06 | -$596.00K derived: sum of 3 quarters · filed 2025-05-06 | -$743.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$300.00K derived: sum of 2 quarters · filed 2025-03-28 | -$447.00K derived: sum of 3 quarters · filed 2025-03-28 | -$593.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$297.00K derived: sum of 2 quarters · filed 2024-11-07 | -$443.00K 10-Q · filed 2024-11-07 | -$583.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$293.00K 10-Q · filed 2024-08-08 | -$433.00K derived: sum of 3 quarters · filed 2024-08-08 | -$574.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$146.00K 10-Q · filed 2024-05-14 | -$286.00K derived: sum of 2 quarters · filed 2024-05-14 | -$427.00K derived: sum of 3 quarters · filed 2024-05-14 | -$543.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$281.00K derived: sum of 2 quarters · filed 2024-03-26 | -$397.00K derived: sum of 3 quarters · filed 2024-03-26 | -$513.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$257.00K derived: sum of 2 quarters · filed 2023-11-07 | -$373.00K 10-Q · filed 2023-11-07 | -$483.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$232.00K 10-Q · filed 2023-08-01 | -$342.00K derived: sum of 3 quarters · filed 2023-08-01 | -$452.00K derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | -$116.00K 10-Q · filed 2023-05-11 | -$226.00K derived: sum of 2 quarters · filed 2023-05-11 | -$336.00K derived: sum of 3 quarters · filed 2023-05-11 | -$391.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$220.00K derived: sum of 2 quarters · filed 2023-03-23 | -$275.00K derived: sum of 3 quarters · filed 2023-03-23 | -$331.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$165.00K derived: sum of 2 quarters · filed 2022-11-04 | -$221.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$111.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$56.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |